Federal Supply Schedule 36F79723D0147
Award Date
6/15/23
Last Date to Order
6/14/28
Federal Agency
Veterans Integrated Service Network 12
Awardee
Immunogen Inc.
Ultimate Awardee
Abbvie Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV is an interim agreement awarded under Federal Supply Schedule (FSS) 65 IB, which covers drugs, pharmaceuticals, and hematology-related products. The contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. federal government, to Immunogen Inc., a for-profit organization, on December 16, 2022. The contract has a ceiling value of $25,000.00 and an ultimate completion date of June 14, 2023. The purpose of this contract is to provide...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Immunomedics, Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master GSA Schedule, with a potential value of $10,000,000. The period of performance is January 1, 2021 through December 31, 2025. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA network through task...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Invivyd, Inc., a for-profit manufacturer of goods. The contract is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $225,000.00 and a period of performance from November 15, 2024 to November 14, 2029. The contract is a multiple award Federal Supply Schedule, meaning that it allows...
This Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Adaptimmune LLC, a foreign-owned for-profit manufacturer, provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The $225,000 multiple-award contract has a period of performance through March 14, 2030. The contract aims to establish a schedule of pre-priced products and services that VISN 12 and other federal...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded to Adaptimmune LLC, a foreign-owned, for-profit manufacturer of goods. The contract, valued at up to $25,000.00, is for the procurement of drugs, pharmaceuticals, and hematology-related products under Schedule 65 IB. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a period of performance from...
This federal contract is an Indefinite Delivery Vehicle (IDV) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is a Federal Supply Schedule (FSS) under Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Avvisto Therapeutics LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $25,000.00 and...
This federal contract IDV was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ionis Pharmaceuticals, Inc. under Federal Supply Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $25,000.00 and a period of performance through August 14, 2025. The contract aims to procure interim pharmaceutical and hematology-related products and services for VISN 12. While the full scope of products and services...
This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12, to Genmab US Inc. for the provision of drugs, pharmaceuticals, and hematology-related products. The contract has a maximum value of $750,000.00 and will run from November 15, 2023 through November 14, 2028. The scope of the contract includes the delivery of a wide range of pharmaceutical and hematology-related items to support VA healthcare facilities within...
This federal contract IDV award is for a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, held by Pharmacyclics LLC, an AbbVie company. The contract has a ceiling value of $761,600,000 and a period of performance through August 28, 2025. The contract vehicle is intended to provide the Department of Veterans Affairs and its Veterans Integrated Service Network 12 with a diverse selection of drugs, pharmaceuticals, and hematology-related products....
The U.S. Department of Veterans Affairs (VA) has awarded Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of goods, a Federal Supply Schedule (FSS) Indefinite Delivery Vehicle (IDV) contract (ID: 36F79724D0026) with a $225,000 ceiling value. This multiple-award IDV, which runs through November 14, 2028, covers Federal Supply Classification 65 I B, encompassing drugs, pharmaceuticals, and hematology-related products. Immunocore Commercial LLC has received multiple firm...